Article Details

Sonic Healthcare USA to Offer Assay to Aid in the Selection of JEMPERLI (dostarlimab-gxly ...

Retrieved on: 2021-07-02 15:00:00

Tags for this article:

Click the tags to see associated articles and topics

Sonic Healthcare USA to Offer Assay to Aid in the Selection of JEMPERLI (dostarlimab-gxly .... View article details on HISWAI: https://www.prnewswire.com/news-releases/sonic-healthcare-usa-to-offer-assay-to-aid-in-the-selection-of-jemperli-dostarlimab-gxly-therapy-in-endometrial-cancer-301325019.html

Excerpt

Endometrial cancers determined to be dMMR (mismatch repair deficient) by Roche's assay may be eligible for treatment with JEMPERLI (dostarlimab- ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up